Drug Development

Type 2 diabetes, a prolific killer, is on a steep ascent.
by Arizona State University
1:39pm
5.17.2017
The license also allows the development and commercial sale of research tools and reagents.
by Oxford Genetics
1:30pm
5.11.2017
Advertisement
A pair of molecules that drive the growth of an aggressive form of brain cancer might hold the key to new therapy options for the deadly disease.
2:48pm
5.10.2017
A new technique for combating both forms of diabetes could be on the horizon.
Digital Editor
|
10:19am
5.8.2017
The treatment consists of iodo-thiocyanate complexes, which are inspired by enzymes and reactive molecules produced by our immune system.
by Frontiers
9:00am
5.3.2017
Advertisement
A new strategy may increase the tolerance of corneal transplants in patients at high risk for rejection.
Digital Reporter
|
@RandDMagazine
3:25pm
5.1.2017
A custom Stimulated Emission Depletion (STED) microscope—could set the stage for future treatment discoveries.
Digital Reporter
|
@RandDMagazine
3:17pm
4.26.2017
Advertisement
The new method lets scientists analyze the effects of gene mutations at an unprecedented scale and speed.
by University of Virginia
12:28pm
4.25.2017
The ingestible technology has demonstrated several thousand -times more sensitivity to gut gases than alternative techniques.
by RMIT University
12:56pm
4.24.2017
A team of chemists developed a simple technique for creating a class of molecules that could yield valuable disease treatments.
Digital Editor
|
@R_Bushey
9:44am
4.20.2017
Advertisement
Researchers from the University of Utah and Stanford University performed two separate preclinical trials with a therapy that targets the ataxin-2 gene.
Digital Editor
|
@R_Bushey
9:19am
4.13.2017
Cystic fibrosis causes the buildup of thick mucus that can clog airways and lead to dangerous infections.
by University of Missouri-Columbia
1:30pm
4.12.2017
Advertisement
Artificially intelligent algorithms can learn to identify amazingly subtle information.
by Stanford University
10:32am
4.6.2017
The combination demonstrated a 59% overall response rate (ORR) in patients with stage III and IV melanoma.
Editor
|
@LauraPanj
3:29pm
4.5.2017
Patients with triple-negative breast cancer (TNBC) — a subtype which accounts for 10 to 20% of all breast cancers— have very few treatment options.
Editor
|
@LauraPanj
9:54am
4.4.2017
Advertisement
The strategy holds promise for combating multidrug resistant bacteria.
by INRS
7:00am
4.4.2017
A novel target for treating Alzheimer's disease could come from a unique cellular vulnerability.
Digital Reporter
|
@RandDMagazine
9:16am
3.28.2017
Advertisement
The partnership will pursue preclinical research and Calico will be responsible for subsequent clinical development and commercialization.
7:00am
3.28.2017
Their experiments in mice suggest a treatment is possible for DNA damage from ageing and radiation.
by University of New South Wales
12:30pm
3.27.2017
The scientists have applied this protocol to the drug Pt103, which is known to have cytotoxic properties but an unknown mechanism of action.
by Vienna University
11:28am
3.22.2017
Advertisement
The worldwide supply of artemisinin relies predominantly on the extraction of the product from the plant Artemisia annua.
by Cardiff University
9:41am
3.15.2017
The study produced a precise atomic map of the frontline antimalarial drug mefloquine.
by Walter and Eliza Hall Institute
3:33pm
3.13.2017
Advertisement
A startup received a big funding boost for its work aimed at combating a serious threat to public health.
Digital Editor
|
@R_Bushey
3:21pm
3.9.2017
Existing treatment requires slow intravenous infusion at a hospital and costs up to $100,000.
Digital Reporter
|
@RandDMagazine
2:41pm
3.7.2017
Researchers are getting closer to refining an experimental treatment for slow heartbeats.
Digital Editor
|
@R_Bushey
2:43pm
2.21.2017
Advertisement
A compound extracted from a deep-water marine sponge could end up helping develop antibacterial solutions against a drug-resistant “super bacteria.”
Digital Reporter
|
@RandDMagazine
10:42am
2.9.2017
The study's authors said the prenylating enzyme, which is called PriB, could prove useful to drug companies.
by Rice University
2:30pm
2.6.2017
Advertisement
New research presented on the interaction between the “accelerator” and the “brake” in the striatum, the part of the brain that controls movements.
Digital Reporter
|
@RandDMagazine
10:42am
1.30.2017
Researchers have identified a genetic variant that doubles an individual's risk of developing ulcerative colitis.
by Wellcome Trust Sanger Institute
10:04am
1.30.2017
Some 30 million Americans suffer from hearing loss, and every year about one in 1,000 babies are born with hearing impairment.
by Harvard Medical School
1:42pm
1.26.2017
Advertisement